“HER2 Expression Discordance between Ductal Carcinoma In situ and Invasive Breast Carcinoma. How to Analyze Oncotype DX ” (2019) Journal of Cancer Research Updates, 8(1), pp. 1–5. doi:10.30683/1929-2279.2019.08.01.